Science News SciGuru.com

---

Leukemia Patients Remain in Remission More Than Two Years After Receiving Genetically Engineered T Cell Therapy Posted: 10 Dec 2012 04:47 AM PST Nine of twelve leukemia patients who received infusions of their own T cells after the cells had been genetically engineered to attack the patients’ tumors responded to the therapy, which was pioneered by scientists in the Perelman School of Medicine at the University of Pennsylvania. Penn Medicine researchers will present the latest results of the trial today at the American Society of Hematology’s Annual Meeting and Exposition. read more

Research Suggests a New Strategy to Prevent or Halt Periodontal Disease Posted: 10 Dec 2012 04:43 AM PST Periodontitis, a form of chronic gum disease that affects nearly half of the U.S. adult population, results when the bacterial community in the mouth becomes unbalanced, leading to inflammation and eventually bone loss. In its most severe form, which affects 8.5 percent of U.S. adults, periodontitis can impact systemic health. read more

You are subscribed to email updates from Science News from SciGuru.com To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610